Richter Gedeon Nyrt.

Other

Actavis Group Ptc Ehf

Ironwood Pharmaceuticals, Inc.

Forest Laboratories Holdings Limited

Anil Chhettry

Mahendra G Dedhiya

Ranajoy Sarkar

Rahul Surana

Mark G Currie

Angelika Fretzen

Ahmad Hashash

Andreas Grill

Ritesh Sanghvi

Yun Mo

Mohammad Mafruhul Bari

Richard Anthony Flynn

Murali Divi

David Farrington

Matthew Miller

Mahendra Dedihiya

The present invention relates to stable and bioavailable immediate release formulations comprising dopamine receptor ligands. Methods of treating various disorders by administering the formulations are also described.

Pharmaceutical formulations containing dopamine receptor ligands

Described herein are micronized powder particles of colistimethate sodium wherein at least 50% by volume of the micronized particles have a diameter of less than 7 micrometers but not less than 3 micrometers and the powder has a total moisture content of from 5 to 10% by weight, for use in the treatment of a pulmonary infection by powder inhalation, wherein the colistimethate sodium is not separated into component form. The micronized powder particles of colistimethate sodium are useful in the treatment of infections caused by gram-negative bacteria, particularly in patients suffering from cystic fibrosis.

Micronized colistimethane sodium pharmaceutical compositions

The present invention relates to stable dosage forms of levomilnacipran and pharmaceutically acceptable salts thereof. Processes for the preparation of these dosage forms and methods of using these dosage forms are also described.

Stable dosage forms of levomilnacipran

Growing community of inventors

Holtsville, NY, United States of America

Anil Chhettry